PwC's Next in Health
Hosted by Glenn Hunzinger, US Health Industries Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech, and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it is policy, AI, innovation, care delivery, business model reinvention, or bold moves shaping the future. If it is happening in health industries, we are talking about it.
PwC's Next in Health
Deals Outlook 2026: What’s ahead for health services
Join Glenn Hunzinger and Dan Farrell as they discuss why 2026 could mark a rebound year for health services dealmaking—driven by higher-quality assets, improving market conditions, and the growing role of technology and AI. They explore how investors are rethinking value creation, from tech-enabled care models to carve-outs and IPOs.
Discussion highlights:
- Stronger earnings, cash flows, and tech-enabled platforms are drawing buyers back
- AI is shifting from a value enhancer to a key driver of margins and valuation
- Carve-outs remain active as health systems and corporates divest non-core assets
- Investors are targeting opportunities across specialties, home-based care, and AI-enabled platforms
- Reopening IPO markets and improved exit options are boosting confidence for 2026
Speakers:
Glenn Hunzinger, US Health Industries Leader, PwC
Dan Farrell, US Health Services Deals Leader, PwC
Linked materials:
- https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html
- https://www.pwc.com/us/en/industries/health-industries/library/medtech-deals-outlook.html
- https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.